0.6327
price down icon2.41%   -0.0156
after-market Handel nachbörslich: .64 0.0073 +1.15%
loading

Finanzdaten der Palisade Bio Inc-Aktie (PALI)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
23.07%
2.843
2.31 3.382 3.593 4.211
Interest Income/Expense
100.00%
0.002
0.001 0.003 0.006 0.002
Operating Income/Loss
23.07%
-2.843
-2.31 -3.382 -3.593 -4.211
Nonoperating Income/Loss
26.25%
0.059
0.08 0.038 0.106 0.131
Income/Loss From Continuing Operations Before Tax
24.84%
-2.784
-2.23 -3.344 -3.487 -4.08
Income/Loss From Continuing Operations After Tax
24.84%
-2.784
-2.23 -3.344 -3.487 -4.08
Net Income/Loss
24.84%
-2.784
-2.23 -3.344 -3.487 -4.08
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.03%
4.7972
4.7956 0.2482 1.5004 1.2285
Diluted Average Shares
0.03%
4.7972
4.7956 0.2482 1.5004 1.2285
Basic Earnings Per Share
23.40%
-0.58
-0.47 -0.69 -2.32 -3.32
Diluted Earnings Per Share
23.40%
-0.58
-0.47 -0.69 -2.32 -3.32
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Kapitalisierung:     |  Volumen (24h):